Screener
Sarepta Therapeutics, Inc. SRPT Business Segments — Clinical Trial Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:ClinicalTrialExpenses.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Compensation and other personnel expenses | 60,725 | 89,839 | 122,655 | 182,923 |
| Up-front and collaboration license fees | — | — | 50,000 | 583,787 |
| Manufacturing expenses | 1,837 | 80,685 | 21,595 | 148,150 |
| Clinical trial expenses | 23,102 | 33,511 | 41,406 | 66,658 |
| Facility- and technology-related expenses (excluding depreciation and amortization) | 23,890 | 28,580 | 46,832 | 56,237 |
| Research and development- other (excluding non-cash items) (1) | 19,847 | 31,843 | 38,518 | 60,314 |
| Selling, general and administrative- other (excluding non-cash items) (2) | 42,462 | 56,322 | 82,655 | 107,464 |
| Roche collaboration reimbursement | (7,169) | (25,689) | (15,358) | (54,170) |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s business segments — clinical trial expenses?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — clinical trial expenses of $23.1M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — clinical trial expenses changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — clinical trial expenses decreased by 31.1% year-over-year, from $33.51M to $23.1M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — clinical trial expenses?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — clinical trial expenses has grown at a -2.8% compound annual growth rate (CAGR), from $135.84M to $124.65M.
- What does business segments — clinical trial expenses mean?
- Reflects the costs incurred for conducting clinical research and development trials within the segment. It provides insight into the segment's commitment to pipeline innovation and future product development.
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — clinical trial expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude